
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
The COVID-19 pandemic in the African continent
Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 104
Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 104
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
Jean B. Nachega, Nadia A. Sam‐Agudu, Rhoderick Machekano, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 3, pp. e216436-e216436
Open Access | Times Cited: 75
Jean B. Nachega, Nadia A. Sam‐Agudu, Rhoderick Machekano, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 3, pp. e216436-e216436
Open Access | Times Cited: 75
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 79
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 79
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access | Times Cited: 1
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access | Times Cited: 1
High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali
Anou M. Somboro, Yacouba Cissoko, Issiaka Camara, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 29
Anou M. Somboro, Yacouba Cissoko, Issiaka Camara, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 29
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
Khalid Hajissa, Md Asiful Islam, Siti Asma Hassan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7257-7257
Open Access | Times Cited: 23
Khalid Hajissa, Md Asiful Islam, Siti Asma Hassan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7257-7257
Open Access | Times Cited: 23
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
Aissatou Abba, Joseph Fokam, Ezéchiel Ngoufack Jagni Semengue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Aissatou Abba, Joseph Fokam, Ezéchiel Ngoufack Jagni Semengue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak response
Ezéchiel Ngoufack Jagni Semengue, Désiré Takou, Marina Potestà, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 3, pp. e0004312-e0004312
Open Access
Ezéchiel Ngoufack Jagni Semengue, Désiré Takou, Marina Potestà, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 3, pp. e0004312-e0004312
Open Access
Post-Omicron SARS-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurvey
Smit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004273-e0004273
Open Access
Smit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004273-e0004273
Open Access
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria
Olatunji Matthew Kolawole, Oyewale Tomori, D. E. Agbonlahor, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236053-e2236053
Open Access | Times Cited: 15
Olatunji Matthew Kolawole, Oyewale Tomori, D. E. Agbonlahor, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236053-e2236053
Open Access | Times Cited: 15
Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020
Karampreet Sachathep, Yen T. Duong, Giles Reid, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 4
Open Access | Times Cited: 3
Karampreet Sachathep, Yen T. Duong, Giles Reid, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 4
Open Access | Times Cited: 3
Epidemiological situation of SARS-CoV-2 infection in Douala, the most populated and highly heterogeneous town of Cameroon: a post-vaccination update
Arlette Flore Moguem Soubgui, Elisee Libert Embolo Enyegue, Loick Pradel Kojom Foko, et al.
Acta Tropica (2023) Vol. 241, pp. 106864-106864
Open Access | Times Cited: 8
Arlette Flore Moguem Soubgui, Elisee Libert Embolo Enyegue, Loick Pradel Kojom Foko, et al.
Acta Tropica (2023) Vol. 241, pp. 106864-106864
Open Access | Times Cited: 8
Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic
Alexandre Manirakiza, Christian Malaka, Jean De Dieu Longo, et al.
Journal of Public Health in Africa (2023) Vol. 14, Iss. 8, pp. 4-4
Open Access | Times Cited: 7
Alexandre Manirakiza, Christian Malaka, Jean De Dieu Longo, et al.
Journal of Public Health in Africa (2023) Vol. 14, Iss. 8, pp. 4-4
Open Access | Times Cited: 7
Observed versus estimated actual trend of COVID-19 case numbers in Cameroon: A data-driven modelling
Arsène Brunelle Sandie, Mathurin Cyrille Tejiokem, Cheikh Fayé, et al.
Infectious Disease Modelling (2023) Vol. 8, Iss. 1, pp. 228-239
Open Access | Times Cited: 6
Arsène Brunelle Sandie, Mathurin Cyrille Tejiokem, Cheikh Fayé, et al.
Infectious Disease Modelling (2023) Vol. 8, Iss. 1, pp. 228-239
Open Access | Times Cited: 6
Spread of SARS-CoV-2 Infection in Adult Populations in Cameroon: A Repeated Cross-Sectional Study Among Blood Donors in the Cities of Yaoundé and Douala
Arsène Brunelle Sandie, Françoise Ngo Sack, Christiane Ingrid Medi Sike, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 2, pp. 266-278
Open Access | Times Cited: 6
Arsène Brunelle Sandie, Françoise Ngo Sack, Christiane Ingrid Medi Sike, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 2, pp. 266-278
Open Access | Times Cited: 6
SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from the Nationwide Household Serosurvey in a Sub-Saharan Africa Country
Samira Zoa‐Assoumou, Paulin N. Essone, Rafiou Adamou, et al.
(2024)
Open Access | Times Cited: 2
Samira Zoa‐Assoumou, Paulin N. Essone, Rafiou Adamou, et al.
(2024)
Open Access | Times Cited: 2
High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May–October 2021) in Matadi, Democratic Republic of the Congo
Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Patrick I. Mpingabo, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Patrick I. Mpingabo, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
The COVID-19 wave was already here: High seroprevalence of SARS-CoV-2 antibodies among staff and students in a Cameroon University
Andrillene Laure Deutou Wondeu, Beatrice Metchum Talom, Giulia Linardos, et al.
Journal of Public Health in Africa (2023) Vol. 14, Iss. 1, pp. 9-9
Open Access | Times Cited: 5
Andrillene Laure Deutou Wondeu, Beatrice Metchum Talom, Giulia Linardos, et al.
Journal of Public Health in Africa (2023) Vol. 14, Iss. 1, pp. 9-9
Open Access | Times Cited: 5
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
Mark Otiende, Amek Nyaguara, Christian Bottomley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Mark Otiende, Amek Nyaguara, Christian Bottomley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic
Alexandre Manirakiza, Christian Malaka, Brice Martial Yambiyo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Alexandre Manirakiza, Christian Malaka, Brice Martial Yambiyo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Modeling SARS-CoV-2 antibody seroprevalence and its determinants in Ghana: A nationally representative cross-sectional survey
Irene Owusu Donkor, Sedzro Kojo Mensah, Duah Dwomoh, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 5, pp. e0001851-e0001851
Open Access | Times Cited: 4
Irene Owusu Donkor, Sedzro Kojo Mensah, Duah Dwomoh, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 5, pp. e0001851-e0001851
Open Access | Times Cited: 4
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid‐19 pandemic and associated factors
Mathurin Cyrille Tejiokem, Hermine Abessolo Abessolo, Joseph Marie Mendimi Nkodo, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 1
Mathurin Cyrille Tejiokem, Hermine Abessolo Abessolo, Joseph Marie Mendimi Nkodo, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 1
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals
Arlette Flore Moguem Soubgui, Wilfred Steve Ndeme Mboussi, Loick Pradel Kojom Foko, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 2, pp. e0002380-e0002380
Open Access | Times Cited: 1
Arlette Flore Moguem Soubgui, Wilfred Steve Ndeme Mboussi, Loick Pradel Kojom Foko, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 2, pp. e0002380-e0002380
Open Access | Times Cited: 1
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study
Adama Sana, Élodie Djemaï, Philippe De Vreyer, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0305850-e0305850
Open Access | Times Cited: 1
Adama Sana, Élodie Djemaï, Philippe De Vreyer, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0305850-e0305850
Open Access | Times Cited: 1
SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil
Daniel Gonçalves Chaves, Ricardo H. C. Takahashi, Felipe Campelo, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 4, pp. 734-742
Open Access | Times Cited: 6
Daniel Gonçalves Chaves, Ricardo H. C. Takahashi, Felipe Campelo, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 4, pp. 734-742
Open Access | Times Cited: 6